Evaluation of cervical cancer screening strategies in women living with HIV in Thailand

Patumrat Sripan; Myrtille Prouté; Nicole Ngo-Giang-Huong; Samreung Rangdaeng; Chaiwat Putiyanun; Guttiga Halue; Prattana Leenasirimakul; Suchart Thongpaen; Sudanee Buranabanjasatean; Sophie Le Coeur; Tristan Delory

doi:10.1002/cac2.70000

Cancer Communications ›› 2025, Vol. 45 ›› Issue (5) : 525 -528. DOI: 10.1002/cac2.70000

LETTER TO THE JOURNAL

Evaluation of cervical cancer screening strategies in women living with HIV in Thailand

Author information +

¹. Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand

². Sigia, Porto, Porto, Portugal

³. Institut de Recherche Pour le Développement (IRD), Montpellier, France

⁴. Associated Medical Sciences (AMS)-PHPT Research Collaboration, Chiang Mai, Thailand

⁵. Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

⁶. Obstetric and Gynecology Department, Chiang Kham Hospital, Phayao, Thailand

⁷. Internal Medicine Department, Phayao Provincial Hospital, Phayao, Thailand

⁸. Internal Medicine Department, Nakornping Hospital, Chiang Mai, Thailand

⁹. Internal Medicine Department, Mahasarakam Hospital, Mahasarakam, Thailand

¹⁰. General Medicine Department, Mae Chan Hospital, Chiang Rai, Thailand

¹¹. Mortality, Health and Epidemiology Department, Institute for Demographic Studies (Ined), Aubervilliers, France

¹². Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France

¹³. Clinical Trial Unit, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France

sophie.lecoeur@phpt.org

tdelory@ch-annecygenevois.fr

Show less

History +

PDF

Cite this article

Download citation ▾

Patumrat Sripan, Myrtille Prouté, Nicole Ngo-Giang-Huong, Samreung Rangdaeng, Chaiwat Putiyanun, Guttiga Halue, Prattana Leenasirimakul, Suchart Thongpaen, Sudanee Buranabanjasatean, Sophie Le Coeur, Tristan Delory. Evaluation of cervical cancer screening strategies in women living with HIV in Thailand. Cancer Communications, 2025, 45(5): 525-528 DOI:10.1002/cac2.70000

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021; 9(2): e161–e9.

[2]

Looker KJ, Ronn MM, Brock PM, Brisson M, Drolet M, Mayaud P, et al. Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc. 2018; 21(6): e25110.

[3]	Verrier F, Le Coeur S, Delory T. Cervical Human Papillomavirus Infection (HPV) and High Oncogenic Risk Genotypes among Women Living with HIV in Asia: A Meta-Analysis. J Clin Med. 2021; 10(9): 1911.

[4]	Wongpratate M, Bumrungthai S. Cervical cancer in Thailand: 2023 update. Obstet Gynecol Sci. 2024; 67(3): 261–9.

[5]	Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017; 64(9): 1228–35.

[6]	de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4): 664–70.

[7]	Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024; 404(10451): 435–44.

[8]	World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: World Health Organization; 2021. second edition: Available from: https://iris.who.int/bitstream/handle/10665/342365/9789240030824-eng.pdf?sequence=1

[9]	Viviano M, DeBeaudrap P, Tebeu PM, Fouogue JT, Vassilakos P, Petignat P. A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa. Int J Womens Health. 2017; 9: 69–79.

[10]	Chung MH, McKenzie KP, De Vuyst H, Richardson BA, Rana F, Pamnani R, et al. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy. AIDS. 2013; 27(18): 2909–19.